{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T14:03:57Z","timestamp":1745589837417,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["99-3-5-19468"],"award-info":[{"award-number":["99-3-5-19468"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02465-8","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T12:05:02Z","timestamp":1722859502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesicles"],"prefix":"10.1007","volume":"41","author":[{"given":"Ahmad","family":"Kooshari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahimeh","family":"Shahriyary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Shahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahshid","family":"Vafajoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"issue":"9","key":"2465_CR1","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang J, et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 2022;9(9):e670\u20137.","journal-title":"Lancet Haematol"},{"key":"2465_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","volume":"6","author":"KC Anderson","year":"2011","unstructured":"Anderson KC, Carrasco RD. Pathogenesis of myeloma. Annu Rev Pathol. 2011;6:249\u201374.","journal-title":"Annu Rev Pathol"},{"key":"2465_CR3","unstructured":"ME, J.F., et al., 2024 Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries."},{"issue":"9983","key":"2465_CR4","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","volume":"385","author":"C R\u00f6llig","year":"2015","unstructured":"R\u00f6llig C, Knop S, Bornh\u00e4user M. Multiple myeloma. Lancet. 2015;385(9983):2197\u2013208.","journal-title":"Lancet"},{"issue":"2","key":"2465_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.drudis.2019.11.008","volume":"25","author":"F Alanazi","year":"2020","unstructured":"Alanazi F, et al. New generation drugs for treatment of multiple myeloma. Drug Discovery Today. 2020;25(2):367\u201379.","journal-title":"Drug Discovery Today"},{"issue":"7","key":"2465_CR6","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/cancers15071990","volume":"15","author":"I Saltarella","year":"2023","unstructured":"Saltarella I, et al. Anti-Angiogenic Activity of Drugs in Multiple Myeloma. Cancers. 2023;15(7):1990.","journal-title":"Cancers"},{"key":"2465_CR7","first-page":"1188","volume":"19","author":"M Gkotzamanidou","year":"2013","unstructured":"Gkotzamanidou M, et al. Angiogenic cytokines profile in smoldering multiple myeloma: no difference compared to MGUS but altered compared to symptomatic myeloma. Med Sci Monit Int Med J Exp Clin Res. 2013;19:1188.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"4","key":"2465_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ajpath.2020.12.016","volume":"191","author":"A Lamanuzzi","year":"2021","unstructured":"Lamanuzzi A, et al. Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma. Am J Pathol. 2021;191(4):748\u201358.","journal-title":"Am J Pathol"},{"issue":"2","key":"2465_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/aps.2013.141","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, et al. Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharmacol Sin. 2014;35(2):230\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"2465_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/stem.2298","volume":"34","author":"JD Anderson","year":"2016","unstructured":"Anderson JD, et al. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of Angiogenesis via nuclear factor-KappaB signaling. Stem Cells. 2016;34(3):601\u201313.","journal-title":"Stem Cells"},{"issue":"7","key":"2465_CR11","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/cancers15071992","volume":"15","author":"NCH Lau","year":"2023","unstructured":"Lau NCH, Yam JWP. From exosome biogenesis to absorption: key takeaways for cancer research. Cancers. 2023;15(7):1992.","journal-title":"Cancers"},{"issue":"6","key":"2465_CR12","first-page":"2873","volume":"39","author":"HM Guo","year":"2018","unstructured":"Guo HM, et al. Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro. Oncol Rep. 2018;39(6):2873\u201380.","journal-title":"Oncol Rep"},{"key":"2465_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10456-011-9251-z","volume":"15","author":"MJ Siemerink","year":"2012","unstructured":"Siemerink MJ, et al. CD34 marks angiogenic tip cells in human vascular endothelial cell cultures. Angiogenesis. 2012;15:151\u201363.","journal-title":"Angiogenesis"},{"key":"2465_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12308-017-0291-1","volume":"10","author":"M Shahidi","year":"2017","unstructured":"Shahidi M, et al. Endothelial tip cell formation induced by chronic lymphocytic leukemia plasma (JAK2 positivity amplified this effect). J Hematop. 2017;10:9\u201315.","journal-title":"J Hematop"},{"issue":"1","key":"2465_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13543776.2017.1236084","volume":"27","author":"IP Singh","year":"2017","unstructured":"Singh IP, Shah P. Tetrahydroisoquinolines in therapeutics: a patent review (2010\u20132015). Expert Opin Ther Pat. 2017;27(1):17\u201336.","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"2465_CR16","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1021\/cr010212u","volume":"102","author":"JD Scott","year":"2002","unstructured":"Scott JD, Williams RM. Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics. Chem Rev. 2002;102(5):1669\u2013730.","journal-title":"Chem Rev"},{"issue":"3","key":"2465_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/molecules28031495","volume":"28","author":"MI Kandinska","year":"2023","unstructured":"Kandinska MI, et al. Synthesis of Novel 1-Oxo-2, 3, 4-trisubstituted tetrahydroisoquinoline derivatives, bearing other heterocyclic moieties and comparative preliminary study of anti-coronavirus activity of selected compounds. Molecules. 2023;28(3):1495.","journal-title":"Molecules"},{"key":"2465_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejmech.2019.02.008","volume":"167","author":"Y Fang","year":"2019","unstructured":"Fang Y, et al. Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2019;167:133\u201345.","journal-title":"Eur J Med Chem"},{"issue":"7","key":"2465_CR19","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.3390\/molecules28073200","volume":"28","author":"M Chrzanowska","year":"2023","unstructured":"Chrzanowska M, Grajewska A, Rozwadowska MD. Diastereoselective synthesis of (\u2013)-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline-1-carboxylic acid via morpholinone derivatives. Molecules. 2023;28(7):3200.","journal-title":"Molecules"},{"issue":"18","key":"2465_CR20","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.2174\/1871520621666210112122913","volume":"21","author":"M Gangapuram","year":"2021","unstructured":"Gangapuram M, et al. Design and synthesis of tetrahydroisoquinoline derivatives as anti-angiogenesis and anti-cancer agents. Anticancer Agents Med Chem. 2021;21(18):2505\u201311.","journal-title":"Anticancer Agents Med Chem"},{"issue":"5","key":"2465_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/CAD.0000000000000718","volume":"30","author":"Y Huang","year":"2019","unstructured":"Huang Y, et al. Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signaling. Anticancer Drugs. 2019;30(5):508\u201316.","journal-title":"Anticancer Drugs"},{"issue":"6","key":"2465_CR22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1538-7836.2009.03434.x","volume":"7","author":"M Bernimoulin","year":"2009","unstructured":"Bernimoulin M, et al. Differential stimulation of monocytic cells results in distinct populations of microparticles. J Thromb Haemost. 2009;7(6):1019\u201328.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2465_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/ecn.2014.0347","volume":"25","author":"H Atmaca","year":"2014","unstructured":"Atmaca H, Uzunoglu S. Anti-angiogenic effects of trabectedin (Yondelis; ET-743) on human breast cancer cells. Eur Cytokine Netw. 2014;25(1):1\u20137.","journal-title":"Eur Cytokine Netw"},{"issue":"14","key":"2465_CR24","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.1074\/jbc.C112.444562","volume":"288","author":"CA Thompson","year":"2013","unstructured":"Thompson CA, et al. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem. 2013;288(14):10093\u20139.","journal-title":"J Biol Chem"},{"issue":"4","key":"2465_CR25","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI66517","volume":"123","author":"AM Roccaro","year":"2013","unstructured":"Roccaro AM, et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest. 2013;123(4):1542\u201355.","journal-title":"J Clin Invest"},{"issue":"4","key":"2465_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1254\/jphs.93.471","volume":"93","author":"N Shimma","year":"2003","unstructured":"Shimma N, et al. Possible role of interleukin-6 in PC12 cell death induced by MPP+ and tetrahydroisoquinoline. J Pharmacol Sci. 2003;93(4):471\u20137.","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"2465_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.5966\/sctm.2014-0267","volume":"4","author":"B Zhang","year":"2015","unstructured":"Zhang B, et al. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4\/\u03b2-catenin pathway. Stem Cells Transl Med. 2015;4(5):513\u201322.","journal-title":"Stem Cells Transl Med"},{"issue":"14","key":"2465_CR28","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1089\/scd.2014.0316","volume":"24","author":"A Shabbir","year":"2015","unstructured":"Shabbir A, et al. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev. 2015;24(14):1635\u201347.","journal-title":"Stem Cells Dev"},{"key":"2465_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10059-011-1042-2","volume":"32","author":"Y-C Choi","year":"2011","unstructured":"Choi Y-C, et al. Regulation of vascular endothelial growth factor signaling by miR-200b. Mol Cells. 2011;32:77\u201382.","journal-title":"Mol Cells"},{"issue":"1","key":"2465_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/0886022X.2022.2056486","volume":"44","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhou X, Wu Y. The miR-26a-5p\/IL-6 axis alleviates sepsis-induced acute kidney injury by inhibiting renal inflammation. Ren Fail. 2022;44(1):551\u201361.","journal-title":"Ren Fail"},{"issue":"7","key":"2465_CR31","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.3390\/nu13072245","volume":"13","author":"O Zanoaga","year":"2021","unstructured":"Zanoaga O, et al. The role of miR-155 in nutrition: modulating cancer-associated inflammation. Nutrients. 2021;13(7):2245.","journal-title":"Nutrients"},{"issue":"1","key":"2465_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12964-022-00904-5","volume":"20","author":"J Gao","year":"2022","unstructured":"Gao J, et al. Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling. Cell Commun Signal. 2022;20(1):97.","journal-title":"Cell Commun Signal"},{"key":"2465_CR33","doi-asserted-by":"publisher","first-page":"116371","DOI":"10.1016\/j.bmc.2021.116371","volume":"46","author":"S Sim","year":"2021","unstructured":"Sim S, et al. Design, synthesis, and biological evaluation of potent 1, 2, 3, 4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-\u03baB signaling pathway. Bioorg Med Chem. 2021;46:116371.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"2465_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-021-00760-9","volume":"20","author":"J Pan","year":"2022","unstructured":"Pan J, et al. Extracellular vesicles derived from glioblastoma promote proliferation and migration of neural progenitor cells via PI3K-Akt pathway. Cell Commun Signal. 2022;20(1):7.","journal-title":"Cell Commun Signal"},{"key":"2465_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tiv.2018.10.007","volume":"54","author":"F-J Cao","year":"2019","unstructured":"Cao F-J, et al. Effects of 2-aryl-1-cyano-1, 2, 3, 4-tetrohydroisoquinolines on apoptosis induction mechanism in NB4 and MKN-45 cells. Toxicol In Vitro. 2019;54:295\u2013303.","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"2465_CR36","first-page":"649161","volume":"2015","author":"Z Qian","year":"2015","unstructured":"Qian Z, et al. The role of extracellular vesicles: an epigenetic view of the cancer microenvironment. Biomed Res Int. 2015;2015(1):649161.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2465_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.apsb.2015.11.002","volume":"6","author":"D Chen","year":"2016","unstructured":"Chen D, et al. Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer. Acta pharmaceutica sinica B. 2016;6(1):93\u20139.","journal-title":"Acta pharmaceutica sinica B"},{"key":"2465_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ejmech.2018.12.065","volume":"164","author":"J Shao","year":"2019","unstructured":"Shao J, et al. Discovery of 2-substituted-N-(3-(3, 4-dihydroisoquinolin-2 (1H)-yl)-2-hydroxypropyl)-1, 2, 3, 4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation. Eur J Med Chem. 2019;164:317\u201333.","journal-title":"Eur J Med Chem"},{"key":"2465_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6150-8-12","volume":"8","author":"AO Batagov","year":"2013","unstructured":"Batagov AO, Kurochkin IV. Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3\u2032-untranslated regions. Biol Direct. 2013;8:1\u20138.","journal-title":"Biol Direct"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02465-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T05:10:57Z","timestamp":1725253857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02465-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["2465"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02465-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Medical Ethics Committee of Iran University of Medical Sciences and conformed to the provisions of the Declaration of Helsinki (IR.IUMS.REC.1399.1337).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"217"}}